(Q41700707)

7 October 2017

Interleukin-10 (IL-10) genotypes in inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

7 October 2017

0 references

inflammation

0 references

author name string

Tagore A

1

1 reference

7 October 2017

Gonsalkorale WM

2

1 reference

7 October 2017

Pravica V

3

1 reference

7 October 2017

Hajeer AH

4

1 reference

7 October 2017

McMahon R

5

1 reference

7 October 2017

Whorwell PJ

6

1 reference

7 October 2017

Sinnott PJ

7

1 reference

7 October 2017

Hutchinson IV

8

1 reference

7 October 2017

1 October 1999

1 reference

7 October 2017

1 reference

7 October 2017

54

1 reference

7 October 2017

386-390

1 reference

7 October 2017

4

1 reference

Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative

7 October 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

Pre-illness dietary factors in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

Alterations of the mucosal immune system in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

Gastrointestinal inflammation. Inflammatory bowel disease in knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

Inflammatory bowel disease management. Some thoughts on future drug developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

An investigation of polymorphism in the interleukin-10 gene promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

Interpretation of large intestinal mucosal biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

7 January 2021

Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

7 January 2021

Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

7 January 2021

Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

7 January 2021

Involvement of interleukin-4 and -10 in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

7 January 2021

Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

7 January 2021

Cytokine gene polymorphism and heart transplant rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

7 January 2021

Cytokine gene polymorphisms predict acute graft rejection following renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

7 January 2021

Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540408.X

7 January 2021

10.1034/J.1399-0039.1999.540408.X

Identifiers

DOI

1 reference

7 October 2017

1 reference